🇺🇸 I131 in United States

20 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dacryostenosis Acquired — 4 reports (20%)
  2. Lacrimation Increased — 4 reports (20%)
  3. Hypothyroidism — 3 reports (15%)
  4. Diarrhoea — 2 reports (10%)
  5. Venoocclusive Liver Disease — 2 reports (10%)
  6. Abdominal Discomfort — 1 report (5%)
  7. Areflexia — 1 report (5%)
  8. Atrial Fibrillation — 1 report (5%)
  9. Blood Calcium Decreased — 1 report (5%)
  10. Blood Potassium Decreased — 1 report (5%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is I131 approved in United States?

I131 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for I131 in United States?

Gustave Roussy, Cancer Campus, Grand Paris is the originator. The local marketing authorisation holder may differ — check the official source linked above.